These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 16513878)
1. Dysbindin genotype and negative symptoms in schizophrenia. DeRosse P; Funke B; Burdick KE; Lencz T; Ekholm JM; Kane JM; Kucherlapati R; Malhotra AK Am J Psychiatry; 2006 Mar; 163(3):532-4. PubMed ID: 16513878 [TBL] [Abstract][Full Text] [Related]
2. Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia. Fanous AH; van den Oord EJ; Riley BP; Aggen SH; Neale MC; O'Neill FA; Walsh D; Kendler KS Am J Psychiatry; 2005 Oct; 162(10):1824-32. PubMed ID: 16199828 [TBL] [Abstract][Full Text] [Related]
3. Is there protective haplotype of dysbindin gene (DTNBP1) 3 polymorphisms for major depressive disorder. Kim JJ; Mandelli L; Pae CU; De Ronchi D; Jun TY; Lee C; Paik IH; Patkar AA; Steffens D; Serretti A; Han C Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):375-9. PubMed ID: 17964051 [TBL] [Abstract][Full Text] [Related]
4. A dysbindin risk haplotype associated with less severe manic-type symptoms in psychosis. Corvin A; Donohoe G; Nangle JM; Schwaiger S; Morris D; Gill M Neurosci Lett; 2008 Jan; 431(2):146-9. PubMed ID: 18162312 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of tagging sequence variants in DTNBP1 shows no association with schizophrenia or with its composite neurocognitive endophenotypes. Peters K; Wiltshire S; Henders AK; Dragović M; Badcock JC; Chandler D; Howell S; Ellis C; Bouwer S; Montgomery GW; Palmer LJ; Kalaydjieva L; Jablensky A Am J Med Genet B Neuropsychiatr Genet; 2008 Oct; 147B(7):1159-66. PubMed ID: 18314870 [TBL] [Abstract][Full Text] [Related]
6. Association study of dysbindin gene with clinical and outcome measures in a representative cohort of Italian schizophrenic patients. Tosato S; Ruggeri M; Bonetto C; Bertani M; Marrella G; Lasalvia A; Cristofalo D; Aprili G; Tansella M; Dazzan P; Diforti M; Murray RM; Collier DA Am J Med Genet B Neuropsychiatr Genet; 2007 Jul; 144B(5):647-59. PubMed ID: 17290445 [TBL] [Abstract][Full Text] [Related]
7. Dysbindin gene (DTNBP1) and schizophrenia in Korean population. Pae CU; Mandelli L; De Ronchi D; Kim JJ; Jun TY; Patkar AA; Serretti A Eur Arch Psychiatry Clin Neurosci; 2009 Apr; 259(3):137-42. PubMed ID: 19252939 [TBL] [Abstract][Full Text] [Related]
8. DTNBP1 haplotype influences baseline assessment scores of schizophrenic in-patients. Pae CU; Drago A; Kim JJ; Patkar AA; Jun TY; Lee C; Mandelli L; De Ronchi D; Paik IH; Serretti A Neurosci Lett; 2008 Aug; 440(2):150-4. PubMed ID: 18562100 [TBL] [Abstract][Full Text] [Related]
9. DTNBP1 (Dystrobrevin binding protein 1) and schizophrenia: association evidence in the 3' end of the gene. Duan J; Martinez M; Sanders AR; Hou C; Burrell GJ; Krasner AJ; Schwartz DB; Gejman PV Hum Hered; 2007; 64(2):97-106. PubMed ID: 17476109 [TBL] [Abstract][Full Text] [Related]
10. Association between the dysbindin gene (DTNBP1) and cognitive functions in Japanese subjects. Hashimoto R; Noguchi H; Hori H; Ohi K; Yasuda Y; Takeda M; Kunugi H Psychiatry Clin Neurosci; 2009 Aug; 63(4):550-6. PubMed ID: 19496996 [TBL] [Abstract][Full Text] [Related]
13. Early visual processing deficits in dysbindin-associated schizophrenia. Donohoe G; Morris DW; De Sanctis P; Magno E; Montesi JL; Garavan HP; Robertson IH; Javitt DC; Gill M; Corvin AP; Foxe JJ Biol Psychiatry; 2008 Mar; 63(5):484-9. PubMed ID: 17945199 [TBL] [Abstract][Full Text] [Related]
14. No association evidence between schizophrenia and dystrobrevin-binding protein 1 (DTNBP1) in Taiwanese families. Liu CM; Liu YL; Fann CS; Yang WC; Wu JY; Hung SI; Chen WJ; Chueh CM; Liu WM; Liu CC; Hsieh MH; Hwang TJ; Faraone SV; Tsuang MT; Hwu HG Schizophr Res; 2007 Jul; 93(1-3):391-8. PubMed ID: 17407805 [TBL] [Abstract][Full Text] [Related]
15. No association of dysbindin with symptom factors of schizophrenia in an Irish case-control sample. Bergen SE; Fanous AH; Kuo PH; Wormley BK; O'Neill FA; Walsh D; Riley BP; Kendler KS Am J Med Genet B Neuropsychiatr Genet; 2010 Mar; 153B(2):700-705. PubMed ID: 19760674 [TBL] [Abstract][Full Text] [Related]
16. Association study of NRG1, DTNBP1, RGS4, G72/G30, and PIP5K2A with schizophrenia and symptom severity in a Hungarian sample. Réthelyi JM; Bakker SC; Polgár P; Czobor P; Strengman E; Pásztor PI; Kahn RS; Bitter I Am J Med Genet B Neuropsychiatr Genet; 2010 Apr; 153B(3):792-801. PubMed ID: 19937977 [TBL] [Abstract][Full Text] [Related]
17. Association study of the dystrobrevin-binding gene with schizophrenia in Australian and Indian samples. Holliday EG; Handoko HY; James MR; McGrath JJ; Nertney DA; Tirupati S; Thara R; Levinson DF; Hayward NK; Mowry BJ; Nyholt DR Twin Res Hum Genet; 2006 Aug; 9(4):531-9. PubMed ID: 16899160 [TBL] [Abstract][Full Text] [Related]
18. The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. Van Den Bogaert A; Schumacher J; Schulze TG; Otte AC; Ohlraun S; Kovalenko S; Becker T; Freudenberg J; Jönsson EG; Mattila-Evenden M; Sedvall GC; Czerski PM; Kapelski P; Hauser J; Maier W; Rietschel M; Propping P; Nöthen MM; Cichon S Am J Hum Genet; 2003 Dec; 73(6):1438-43. PubMed ID: 14618545 [TBL] [Abstract][Full Text] [Related]
19. Association of the DTNBP1 locus with schizophrenia in a U.S. population. Funke B; Finn CT; Plocik AM; Lake S; DeRosse P; Kane JM; Kucherlapati R; Malhotra AK Am J Hum Genet; 2004 Nov; 75(5):891-8. PubMed ID: 15362017 [TBL] [Abstract][Full Text] [Related]
20. Analysis of HapMap tag-SNPs in dysbindin (DTNBP1) reveals evidence of consistent association with schizophrenia. Voisey J; Swagell CD; Hughes IP; Lawford BR; Young RM; Morris CP Eur Psychiatry; 2010 Oct; 25(6):314-9. PubMed ID: 20615671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]